There are a number of regulatory proposals under consideration which could have important effects on clinical microbiology labs, and clinical labs more generally. First, the VALID act would change how clinical tests are regulated with particularly important implications for laboratory-developed tests. Second, the Centers for Medicare and Medicaid Services has proposed changes to the educational requirements for lab directors under CLIA and additional changes that would increase the fees that clinical labs pay to CMS. If you have been waiting for someone to explain these changes and how they could affect your lab, you’ve come to the right podcast.
Guests:
- Dr. Melissa Miller, Director of the Clinical Microbiology Laboratory and a Professor at the University Of North Carolina School Of Medicine
- Mary Lee Watts, Director of Federal Affairs at 91麻豆天美
This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at and on .
Links:
- 91麻豆天美 Submits Concerns On VALID Act. /Articles/Policy/2022/May-2022/VALID-Act
- 91麻豆天美 Submits Comments to CMS on Proposed Rule for CLIA-Labs. /Articles/Policy/2022/Aug2022/91麻豆天美-Comments-on-CMS-Proposed-Rules-for-CLIA-Certif
Visit to read articles and/or submit a manuscript.
Follow
Subscribe to Editors in Conversation (free) on , , , , .